Skip to main content

Punctate Inner Choroidopathy

  • Chapter
Intraocular Inflammation

Abstract

Punctate inner choroidopathy (PIC) is a rare, idiopathic, inflammatory disease confined to the inner choroid and retinal pigment epithelium that occurs in otherwise healthy, predominantly young adult myopic women. PIC was first described in 1984 in a series of ten women by Watzke et al. [1]. In the largest series reported to date of 77 patients with the diagnosis of PIC who responded to a nationwide survey, 90 % of the patients were women, 85 % were myopic, and the median age of the participants was 30 years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Watzke RC et al (1984) Punctate inner choroidopathy. Am J Ophthalmol 98(5):572–584

    Article  CAS  PubMed  Google Scholar 

  2. Gerstenblith AT et al (2007) Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 114(6):1201–1204

    Article  PubMed  Google Scholar 

  3. Albert LJ, Inman RD (1999) Molecular mimicry and autoimmunity. N Engl J Med 341(27):2068–2074

    Article  CAS  PubMed  Google Scholar 

  4. Tiffin PA et al (1996) Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol 80(1):90–91

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Izatt JA et al (1994) Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol 112(12):1584–1589

    Article  CAS  PubMed  Google Scholar 

  6. Channa R et al (2012) Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect 2(3):113–120

    Article  PubMed Central  PubMed  Google Scholar 

  7. Zhang X et al (2013) Spectral-domain optical coherence tomographic findings at each stage of punctate inner choroidopathy. Ophthalmology 120(12):2678–2683

    Google Scholar 

  8. Turkcuoglu P et al (2011) Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm 19(4):286–292

    Article  CAS  PubMed  Google Scholar 

  9. Brueggeman RM, Noffke AS, Jampol LM (2002) Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 120(7):996

    Article  PubMed  Google Scholar 

  10. Levy J et al (2005) Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 40(5):605–608

    Article  PubMed  Google Scholar 

  11. Thorne JE et al (2005) Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 112(8):1472–1477

    Article  PubMed  Google Scholar 

  12. Cirino AC, Mathura JR Jr, Jampol LM (2006) Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 26(9):1091–1092

    Article  PubMed  Google Scholar 

  13. Leslie T et al (2005) Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 89(2):147–150

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Chatterjee S, Gibson JM (2003) Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 87(7):925–927

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Verteporfin R et al (2002) Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22(1):6–18

    Article  Google Scholar 

  16. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119(2):198–207

    CAS  PubMed  Google Scholar 

  17. Rogers AH et al (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134(4):566–576

    Article  PubMed  Google Scholar 

  18. Fong KC et al (2008) Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. Eye (Lond) 22(4):528–533

    Article  CAS  Google Scholar 

  19. Gragoudas ES et al (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805–2816

    Article  CAS  PubMed  Google Scholar 

  20. Nguyen QD et al (2005) Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia. Br J Ophthalmol 89(10):1368–1370

    PubMed Central  CAS  PubMed  Google Scholar 

  21. Michels S et al (2005) Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112(6):1035–1047

    Article  PubMed  Google Scholar 

  22. Chan WM et al (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143(6):977–983

    Article  CAS  PubMed  Google Scholar 

  23. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Macular Photocoagulation Study Group (1989) Arch Ophthalmol, 107(3):344–352

    Google Scholar 

  24. Eckstein M et al (1998) Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye (Lond) 12(Pt 5):775–780

    Article  Google Scholar 

  25. Melberg NS et al (1996) Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 103(7):1064–1067, discussion 1067-8

    Article  CAS  PubMed  Google Scholar 

  26. Olsen TW et al (1996) Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 103(12):2061–2069

    Article  CAS  PubMed  Google Scholar 

  27. Coco RM, de Souza CF, Sanabria MR (2007) Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm 15(1):27–29

    Article  PubMed  Google Scholar 

  28. Flaxel CJ et al (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond) 12(Pt 2):266–272

    Article  Google Scholar 

  29. Brown J Jr et al (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103(7):1100–1105

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Quan Dong Nguyen MD, MSc .

Editor information

Editors and Affiliations

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 51

Puctate inner choroidopathy (PPTX 1760 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gerstenblith, A.T., Sepah, Y.J., Maya, J.R., Do, D.V., Nguyen, Q.D. (2016). Punctate Inner Choroidopathy. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_93

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_93

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics